Gallant
PrivateLast Round
Series B
Jun 30, 2025
Total Funding Raised
$51M
Company Overview
Gallant is a biotechnology company that develops a pet health technology platform providing stem cell therapy and regenerative medicine to treat diseases in companion animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gallant Comparables
Compare Gallant with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| StemcellX | 86% | |
| Animal Cell Therapies, Inc. | 84% | |
| VetStem Biopharma | 84% |
Gallant Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 30, 2025 | ||||
| Series A | Jan 8, 2024 | ||||
| Seed | Oct 24, 2019 | ||||
| Seed | Aug 5, 2019 |
Gallant Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Slow Ventures | Seed |
| Maveron | Seed |
| Digitalis Ventures | Series A, Series B |
| Hill Creek Capital | Series A, Series B |
| Science Inc. | Seed |
| BOLD Capital Partners | Seed, Series B, Series A |
| NovaQuest Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 27, 2026
Partnering with MWI Animal Health for ultra-low temperature cold chain logistics.
- Sep 15, 2025
Launched GallantU, an online continuing education platform for veterinary professionals.
Gallant Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gallant's valuation, stock price, and market status.
Is Gallant a public or private company?
Gallant is a private company.
What is the current stock price of Gallant?
Gallant is a private company with no public stock price. No recent secondary market data is available.
How much is Gallant worth (valuation)?
Valuation information for Gallant is not publicly available.
Can I buy Gallant stock?
Gallant shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Gallant's last funding round?
Gallant's most recent funding round was Series B on June 30, 2025.
Who are the main investors in Gallant?
Key investors in Gallant include Digitalis Ventures, Bold Capital.
Will Gallant IPO soon?
No public IPO plans have been announced for Gallant.
How can I track Gallant secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gallant's secondary market activity and sign up for updates.